The lung stents market is expected to reach USD 105.6 Million by 2022 from an estimated USD 76.3 Million in 2017, at a CAGR of 6.7%.
Seattle, WA -- (SBWIRE) -- 12/12/2017 -- The report "Airway Stent / Lung Stent Market by Type (Tracheal, Laryngeal), Product (Self expandable, Balloon expandable), Material (Metal (Nitinol, Stainless Steel) Silicone, Hybrid), Procedure (Bronchoscopy (Rigid, Flexible), Laryngoscopy) - Global Forecast to 2022", The lung stents market is expected to reach USD 105.6 Million by 2022 from an estimated USD 76.3 Million in 2017, at a CAGR of 6.7%. The rapidly increasing geriatric population, rising preference for minimally invasive procedures, high prevalence of tobacco smoking, and rising prevalence of lung cancer and other respiratory diseases are the major factors driving the growth of the lung stents market. On the other hand, stringent regulations for the approval of lung stents and the availability of treatment alternatives for lung diseases are the major factors that are expected to restrain the growth of this market during the forecast period.
Browse 169 Market Data Tables and 36 Figures spread through 181 Pages and in-depth TOC on "Airway Stent / Lung Stent Market"
Early buyers will receive 10% customization on reports.
"By product, the self-expandable stents segment accounted for the largest share of the lung stents market in 2016."
On the basis of product, the self-expandable stents segment accounted for the largest share of the global lung stents market. The large share of this segment is due to their easy removability, decreased possibility of complications, and the higher adoption of this stents by intervention pulmonologists.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownload.asp?id=32315890
"By type, the tracheal stents segment accounted for the largest share of the lung stents market in 2016."
On the basis of type, the tracheal stents segment accounted for the largest share of the global lung stents market. The large share of this segment is due to high incidence of lung cancer, increasing prevalence of chronic diseases such as COPD & asthma, rapid growth in the geriatric population, and improving healthcare affordability in developed countries.
"By material, the metal stents segment held the largest market share of lung stents market in 2016."
Based on material, the metal stents segment accounted for the largest share of the lung stents market. The large share of this segment can be attributed to their ease of insertion, thinner walls as compared to silicone stents, a lower possibility of dislodgment or migration, and ability to adapt to the twisted airway.
Download Sample Pages:- https://www.marketsandmarkets.com/requestsample.asp?id=32315890
"By procedure, the bronchoscopy segment held the largest market share of lung stents market in 2016."
Based on procedure, the bronchoscopy segment accounted for the largest share of the lung stents market. The large share of this segment can be attributed to the wide application of bronchoscopy in the placement of stents during the treatment of airway/lung diseases. Moreover, the adoption of bronchoscopy by healthcare providers is greater as compared to laryngoscopy.
"North America dominated the market in 2016."
North America accounted for the largest share of the lung stents market in 2016, followed by Europe and Asia Pacific. The presence of a highly developed healthcare system, rising geriatric population, increasing incidence of lung cancer, quick adoption of new and innovative products, and a large number of lung stents manufacturing companies in this region are the major factors responsible for the large share of North America in the global lung stents market.
The prominent players in the global lung stents market are Boston Scientific (US), C.R. Bard (US), Teleflex (US), Cook Group (US), Merit Medical Systems (US), Novatech (France), Fuji Systems (Japan), Taewoong Medical (South Korea), ENDO-FLEX (Germany), M.I.Tech (South Korea), Micro-Tech (Nanjing) (China), EFER ENDOSCOPY (France), Hood Laboratories (US), S&G BIOTECH (South Korea), Changzhou Health Microport Medical Device (China), and Kapitex Healthcare (UK).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441